NEW YORK, Jul 07, 2010 (BUSINESS WIRE) --
Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and
marketer of pharmaceutical products, will release its Fiscal 2011 First
Quarter financial results before the U.S. stock market opens on Tuesday,
July 20, 2010. At 10:00 AM EDT, Forest will host a conference call where
Dr. Lawrence Olanoff, President and Chief Operating Officer and Frank
Perier, Senior Vice President-Finance and Chief Financial Officer, will
discuss the financial results and relevant company and industry topics.
The conference call will be webcast live beginning at 10:00 AM EDT on
the Company's website www.frx.com
and also on the website www.streetevents.com.
Please log on to either website at least fifteen minutes prior to the
conference call as it may be necessary to download software to access
the call. A replay of the conference call will be available until August
6, 2010 at both websites and also by dialing 1-800-642-1687 (US
investors) or +1-706-645-9291 (international investors), Conference Call
ID 84971239.
About Forest Laboratories
Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company
with a long track record of building partnerships and developing and
marketing products that make a positive difference in people's lives. In
addition to its well-established franchises in therapeutic areas of the
central nervous and cardiovascular systems, Forest's current pipeline
includes product candidates in all stages of development and across a
wide range of therapeutic areas. The Company is headquartered in New
York, NY. To learn more about Forest Laboratories, visit www.frx.com.
Except for the historical information contained herein, this release
contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve a
number of risks and uncertainties, including the difficulty of
predicting FDA approvals, the acceptance and demand for new
pharmaceutical products, the impact of competitive products and pricing,
the timely development and launch of new products, and the risk factors
listed from time to time in Forest Laboratories' Annual Report on Form
10-K, Quarterly Report on Form 10-Q, and any subsequent SEC filings.
SOURCE: Forest Laboratories, Inc.
Forest Laboratories, Inc.
Frank J. Murdolo, 1-212-224-6714
Vice President - Investor Relations
frank.murdolo@frx.com